These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 9409318)

  • 1. Polymorphism of angiotensin converting enzyme gene is associated with circulating levels of plasminogen activator inhibitor-1.
    Kim DK; Kim JW; Kim S; Gwon HC; Ryu JC; Huh JE; Choo JA; Choi Y; Rhee CH; Lee WR
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3242-7. PubMed ID: 9409318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Association of angiotensin I-converting enzyme gene polymorphism with ACE and PAI-1 levels in Guangdong Chinese Han patients with essential hypertension].
    Zhang YL; Zhou SX; Lei J; Zhang JM
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Nov; 27(11):1681-4. PubMed ID: 18024289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen activator inhibitor-1 and angiotensin I converting enzyme gene polymorphism in patients with hypertension.
    Jeng JR; Harn HJ; Yueh KC; Jeng CY; Shieh SM
    Am J Hypertens; 1998 Feb; 11(2):235-9. PubMed ID: 9524054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of association between the angiotensin-converting enzyme insertion/deletion polymorphism and plasminogen activator inhibitor-1 antigen levels in the National Heart, Lung, and Blood Institute Family Heart Study.
    Pankow JS; Arnett DK; Borecki IB; Hunt SC; Eckfeldt JH; Folsom AR; Djoussé L
    Blood Coagul Fibrinolysis; 2000 Sep; 11(6):551-8. PubMed ID: 10997795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Plasminogen activator inhibitor-1 (PAI-1) 4G/5G and angiotensin converting enzyme (ACE) I/D gene polymorphisms and fibrinolytic activity in patients with essential hypertension and dyslipidemia].
    Jastrzebska M; Widecka K; Ciechanowicz A; Goracy I; Wesołowska T; Torbus-Lisiecka B; Foltyńska-Nowakowska A; Naruszewicz M
    Pol Arch Med Wewn; 2005 Jan; 113(1):7-20. PubMed ID: 16130596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen activator inhibitor-1 (PAI-1) antigen plasma levels in subjects attending a metabolic ward: relation to polymorphisms of PAI-1 and angiontensin converting enzyme (ACE) genes.
    Margaglione M; Grandone E; Vecchione G; Cappucci G; Giuliani N; Colaizzo D; Celentano E; Panico S; Di Minno G
    Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):2082-7. PubMed ID: 9351375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin converting enzyme insertion/deletion polymorphism is associated with plasma antigen levels of plasminogen activator inhibitor-1 in healthy Japanese population.
    Matsubara Y; Hayakawa T; Tsuda T; Takeshita E; Watanabe G; Murata M; Watanabe K; Ikeda Y
    Blood Coagul Fibrinolysis; 2000 Mar; 11(2):115-20. PubMed ID: 10759003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy1.
    Kimura H; Gejyo F; Suzuki Y; Suzuki S; Miyazaki R; Arakawa M
    Kidney Int; 1998 Nov; 54(5):1659-69. PubMed ID: 9844142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin converting enzyme DD genotype affects the changes of plasma plasminogen activator inhibitor-1 activity after primary percutaneous transluminal coronary angioplasty in acute myocardial infarction patients.
    Prisco D; Fatini C; Battaglini B; Gensini F; Fedi S; Falai M; Chioccioli M; Gori AM; Margheri M; Gensini GF
    Int J Clin Lab Res; 2000; 30(4):179-85. PubMed ID: 11289708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-1-converting enzyme (ACE) gene polymorphism, plasma ACE levels, and their association with the metabolic syndrome and electrocardiographic coronary artery disease in Pima Indians.
    Nagi DK; Foy CA; Mohamed-Ali V; Yudkin JS; Grant PJ; Knowler WC
    Metabolism; 1998 May; 47(5):622-6. PubMed ID: 9591757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance?
    Panahloo A; Andrès C; Mohamed-Ali V; Gould MM; Talmud P; Humphries SE; Yudkin JS
    Circulation; 1995 Dec; 92(12):3390-3. PubMed ID: 8521557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The influence of I/D polymorphism of the angiotensin I converting enzyme (ACE) gene and 4G/5G polymorphism of plasminogen activator inhibitor (PAI-1) gene promoter on the haemostatic system in patients with essential hypertension and dyslipidemia].
    Nowakowska A
    Ann Acad Med Stetin; 2005; 51(1):95-105. PubMed ID: 16496609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACE/DD genotype is associated with hemostasis balance disturbances reflecting hypercoagulability and endothelial dysfunction in patients with untreated hypertension.
    Makris TK; Stavroulakis GA; Dafni UG; Gialeraki AE; Krespi PG; Hatzizacharias AN; Tsoukala CG; Vythoulkas JS; Kyriakidis MK
    Am Heart J; 2000 Nov; 140(5):760-5. PubMed ID: 11054622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAI-1 plasma levels in a general population without clinical evidence of atherosclerosis: relation to environmental and genetic determinants.
    Margaglione M; Cappucci G; d'Addedda M; Colaizzo D; Giuliani N; Vecchione G; Mascolo G; Grandone E; Di Minno G
    Arterioscler Thromb Vasc Biol; 1998 Apr; 18(4):562-7. PubMed ID: 9555861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinations of fibrinolytic gene polymorphisms (plasminogen activator inhibitor type 1 4G/5G, factor XIII Val34Leu and angiotensin-converting enzyme I/D) in women with idiopathic infertility.
    Velickovic J; Jelicic M; Stojkovic O
    Blood Coagul Fibrinolysis; 2021 Mar; 32(2):103-107. PubMed ID: 33555692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does long-term angiotensin converting enzyme inhibition affect the concentration of tissue-type plasminogen activator-plasminogen activator inhibitor-1 in the blood of patients with a previous myocardial infarction.
    Pedersen OD; Gram J; Jeunemaitre X; Billaud E; Jespersen J
    Coron Artery Dis; 1997 May; 8(5):283-91. PubMed ID: 9285181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of plasminogen activator inhibitor-1 4G/4G genotype and type 2 diabetic nephropathy in Chinese patients.
    Wong TY; Poon P; Szeto CC; Chan JC; Li PK
    Kidney Int; 2000 Feb; 57(2):632-8. PubMed ID: 10652041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of the coronary artery disease risk associated with the presence of traditional risk factors by insertion/deletion polymorphism of the ACE gene.
    Niemiec P; Zak I; Wita K
    Genet Test; 2007; 11(4):353-9. PubMed ID: 18294050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of estrogen and angiotensin-converting enzyme inhibition on plasminogen activator inhibitor-1 in healthy postmenopausal women.
    Brown NJ; Abbas A; Byrne D; Schoenhard JA; Vaughan DE
    Circulation; 2002 Jan; 105(3):304-9. PubMed ID: 11804984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of perindopril treatment on hemostatic function in patients with essential hypertension in relation to angiotensin converting enzyme (ACE) and plasminogen activator inhibitor-1 (PAI-1) gene polymorphisms.
    Jastrzebskal M; Widecka K; Naruszewicz M; Ciechanowicz A; Janczak-Bazan A; Foltynska A; Goracy I; Chetstowski K; Wesotowska T
    Nutr Metab Cardiovasc Dis; 2004 Oct; 14(5):259-69. PubMed ID: 15673060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.